NSCLC, adding nivolumab to tivozanib in metastatic RCC underwhelms, and T-DXd shows improvement in HER2+ breast cancer with brain metastases.

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio? Summit Therapeutics Inc.

Anura Kumara Dissanayake’s strong showing reveals voter weariness with leadership that has led to a national economic crisis and crushing hardship for many people. By Mujib Mashal and Pamodi ...

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors ...

Kyiv has struggled for months to counter the highly-destructive bombs which have been laying waste to the eastern part of the country ...